Human lesion studies

Annals of the New York Academy of Sciences

Volumn 811, Issue , 1997, Pages 207-225

  Foster, Valentin ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN; THROMBOPLASTIN;

ARTERY ENDOTHELIUM; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; HUMAN; LIPID BLOOD LEVEL; THROMBOSIS;

EID: 0030876707     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52003.x     Document Type: Conference Paper

References (44)

1. FUSTER, V., L. BADIMON, J. J. BADIMON & J. H. CHESEBRO. 1992. The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 326(5): 310-318.
2. ROSS, R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362(6423): 801-809.
3. FUSTER, V. 1994. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology. Circulation 90(4): 2126-2146.
4. FUSTER, V., J. T. FALLON & Y. NEMERSON. 1996. Coronary thrombosis. Lancet (Suppl.) 348: S7-S9.
5. STARY, H. C., A. B. CHANDLER, R. E. DINSMORE, V. FUSTER, S. GLAGOV, W. INSULL, M. E. ROSENFELD, C. J. SCHWARTZ, W. D. WAGNER & R. W. WISSLER. 1995. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355-1374.
6. STEINBERG, D. 1991. Antioxidants and atherosclerosis. A current assessment. Circulation 84(3): 1420-1425.
7. Ross, R. & V. FUSTER. 1996. The pathogenesis of atherosclerosis. In Arteriosclerosis and Coronary Artery Disease. V. Fuster, R. Ross & E. Topol, Eds. 1: 441-460. Lippincott-Raven Publishers. Philadelphia, PA.
8. BADIMON, L., J. J. BADIMIN & V. FUSTER. 1990. Regression of atherosclerotic lesions by high density lipoprotein plasma fractions in the cholesterol-fed rabbit. J. Clin. Invest. 85: 1234-1241.
9. MONCADA, S., R. GRYGLEWSKI, S. BUNTING & J. R. VANE. 1976. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263(5579): 663-665.
10. FURCHGOTT, R. F. & J. V. ZAWADZKI. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288(5789): 373-376.
11. YANAGISAWA, M., H. KURIHARA, S. CHIMAERA et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332(6163):411-415.
12. EGASHIRA, K., T. INOU, Y. HIROOKA et al. 1993. Impaired coronary blood flow response to acetylcholine in patient with coronary risk factors and proximal atherosclerotic lesions. J. Clin. Invest. 93(1): 29-37.
13. REDDY, K. G., R. N. NAIR, H. M. SHEEHAN & J. M. HODGSON. 1994. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J. Am. Coll. Cardiol. 25(4): 833-843.
14. RICHARDSON, P. D., M. J. DAVIES & G. V. BORN. 1989. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 2(8669): 1462-1463.
15. FALK, E., P. K. SHAH & V. FUSTER. 1995. Coronary plaque disruption. Circulation 92: 657-671.
16. AMBROSE, J. A., M. TANNENBAUM, D. ALEXPOULOS et al. 1988. Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol. 12: 56-62.
17. LITTLE, W. C., M. CONSTANTINESCU, R. J. APPLEGATE et al. 1988. Can coronary angiography predict the sile of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78(5 Pt. 1): 1157-1166.
18. DAVIES, M. J., P. D. RICHARDSON, N. WOOLF, D. R. KATZ & J. MANN. 1993. Risk of thrombosis in human atherosclerotic plaques role of extracellular lipid, macrophage, and smooth muscle content. Br. Heart J. 69(5): 377-381.
19. MACISSAC, A. L., J. D. THOMAS & E. J. TOPOL. 1993. Toward the quiescent coronary plaque. J. Am. Coll. Cardiol. 22: 1228-1241.
20. MORENO, P. R., E. FALK, I. F. PALACIOS, J. B. NEWELL, V. FUSTER & J. T. FALLON. 1994. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90(2): 775-778.
21. SHAH, P. K., E. FALK, J. J. BADIMON, A. FERNANDEZ-ORTIZ, A. MAILHAC, G. VILLAREAL-LEVY, J. T. FALLON, J. REGNSTROM & V. FUSTER. 1995. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92: 1565-1569.
22. GALIS, Z. S., G. K. SUKHOVA, M. W. LARK & P. LIBBY. 1994. Increased expression of matrix metalloproteinase and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94(6): 2493-2503.
23. GALIS, Z. S., G. K. SUKHOVA, R. KRANZHOFER, S. CLARK & P. LIBBY. 1995. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. USA 92(2): 402-406.
24. DEWOOD, M. A., J. SPORES, R. NOTSKE et al. 1980. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N. Engl. J. Med. 303(16): 897-902.
25. FERNANDEZ-ORTIZ, A., J. J. BADIMON, E. FALK, V. FUSTER, B. MEYER, A. MAILHAC, D. WENG, P. K. SHAH & L. L. BADIMON. 1994. Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture. J. Am. Coll. Cardiol. 23: 1562-1569.
26. BANNER, D. W. et al. 1996. The crystal structure of the complex of blood coagulation factor Villa with soluble tissue factor. Nature 380: 41-46.
27. WILCOX, J. N. & K. M. SMITH, S. M. SCHWARTZ & D. GORDON. 1989. Localization of tissue factor in normal vessel wall and in the atherosclerotic plaque. Proc. Natl. Acad. Sci. USA 86: 2839-2843.
28. TOSCHI, V., R. GALLO, M. LETTINO, J. T. FALLON, A. FERNANDEZ-ORTIZ, L. BADIMON, J. H. CHESEBRO, Y. NEMERSON, V. FUSTER & J. J. BADIMON. 1997. Tissue factor predicts the thrombogenicity of human atherosclerotic plaque components. Circulation (In press).
29. MARMUR, J. D. E., S. V. THIRUVIKRAMAN, B. S. FYFE, A. GUHA, S. H. SHARMA, J. H. AMBROSE, J. T. FALLON, Y. NEMERSON & M. TAUBMAN. 1996. The identification of active tissue factor in human coronary atheroma. Circulation 94: 1226-1232.
30. MORENO, P. R., V. H. BERNARDI, J. LOPEZ-CUELLAR, I. F. PALACIOS, H. K. GOLD, Y. NEMERSON, V. FUSTER & J. T. FALLON. 1996. Macrophages, smooth muscle cells and tissue factor in unstable angina: Implications for cell mediated thrombogenicity in acute coronary syndromes. Circulation 94: 3090-3097.
31. BADIMON, J. J., M. LETTINO, V. TOSCHI, R. GALLO, J. T. FALLON, Y. NEMERSON, L. BADIMON, J. H. CHESEBRO & V. FUSTER. 1995. Inhibitory effects of TFTI on thrombus formation triggered by lipid-rich human atherosclerotic plaques. Circulation 92(Suppl I): I-693.
32. BLANKENHORN, D. H. & H. N. HODIS. 1994. George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal. Arterioscler. Thromb. 14(2): 177-192.
33. SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY GROUP. 1994. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344(8934): 1383-1389.
34. THE CHOLESTEROL AND RECURRENT EVENTS (CARE) GROUP OF INVESTIGATORS. AMERICAN COLLEGE OF CARDIOLOGY SCIENTIFIC SESSION. MARCH, 1996.
35. SHEPARD, J., S. M. COBBE, I. FORD, et al. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 333: 1301-1307.
36. BROWN, B. G., X. O. ZHAO, D. E. SACCO & J. J. ALBERS. 1993. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 87(6): 1781-1791.
37. SMALL, D. M. 1988. Progression and regression of atherosclerotic lesions. Insights from lipid-physical biochemistry. Arteriosclerosis 8: 103-129.
38. LOREE, H. M., B. J. TOBIAS, L. J. GIBSON, R. D. KAMM, D. M. SMALL & R. T. LEE. 1994. Mechanical properties of model atherosclerotic lesion lipid pool. Athero. Thromb. 14: 230-234.
39. GUYTON, J. R. & K. F. KLEMP. 1994. Development of the atherosclerotic core region. Chemical and ultrastructure analysis of microdissected atherosclerotic lesions from human aorta. Arterioscler. Thromb. 14: 1305-1314.
40. 13C-NMR spectroscopy of human atherosclerotic lesions: Relation between fatty acid saturation, cholesteryl ester content, and luminal obstruction. Arterioscl. Thromb. 14: 1951-1957.
41. NOBUYOSHI, M. 1991. J. Am. Coll. Cardiol. 18: 904-910.
42. GIROUD, D. 1988. Am. J. Cardiol. 12: 56-62.
43. LOREE. 1992. Circ. Res. 71: 850.
44. TAEYMANS. 1992. Circulation 85: 78.